Famotidine 30mg Extended-Release Tablets from Germany
Extended-release famotidine 30mg tablets provide 24-hour control of acid production for chronic GERD patients. Containing famotidine in retail-measured doses, they are under HTS 3004.90.92.54.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Pharmacokinetic studies proving extended-release profile for classification support
• Matrix polymer content declaration to avoid parts classification